Terminated PHASE2 INTERVENTIONAL 2-arm NCT01298960

Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients (FUNDEX001)

Phase II Randomized Study of Cotreatment With Growth Hormone in a Long GnRH Agonist Protocol in Women With Previous Poor Ovarian Response

Sponsor: Fundacion Dexeus

Conditions Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer

Interventions Somatropin

Updated 7 times since 2017 Last updated: Feb 10, 2020 Started: Feb 28, 2011 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Fundacion Dexeus

See all terminations from Fundacion Dexeus

Listed as NCT01298960, this PHASE2 trial focuses on Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer and remains terminated or withdrawn. Sponsored by Fundacion Dexeus, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Jan 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Mar 2020 — Jan 2021 [monthly]

Terminated PHASE2

Status: Suspended → Terminated

▶ Show 2 earlier versions

Jun 2018 — Mar 2020 [monthly]

Suspended PHASE2
Jan 2017 — Jun 2018 [monthly]

Suspended PHASE2

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion Dexeus

Data source: Fundacion Dexeus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain